Phacilitate Leaders World

An insurer's view of Advanced Therapies

An insurer's view of Advanced Therapies

Dr Naomi Aronson, Executive Director, TEC, Blue Cross Blue Shield Association - Speaker Interview 

Naomi Aronson, Ph.D., is the Executive Director of Clinical Evaluation, Innovation, and Policy, Blue Cross and Blue Shield Association (BCBSA) . Her areas of leadership include comparative effectiveness, patient centered research, safety surveillance, regulatory science and methodological standards.



 

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK